Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 3.45 is 37% below its 5-year average of 5.45, near the low end of its 5-year range (2.79–21.68).
As of the fiscal period ended Tuesday, June 30, 2026. 11.76% below its 12-month average of 3.91.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 3.45.
CURRENT RATIO
3.45
CURRENT RATIO AVG TTM
3.91
CURRENT RATIO AVG 3Y
4.52
CURRENT RATIO AVG 5Y
5.45
CURRENT RATIO AVG 10Y
9.03
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-11.76%
CURRENT VS 3Y AVG
-23.66%
CURRENT VS 5Y AVG
-36.68%
CURRENT VS 10Y AVG
-61.78%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
-7.96%
vs the sector median at left
Rhythm Pharmaceuticals, Inc.
Market Cap
$6.23B
Current Ratio
3.45
TTM Avg
3.91
3Y Avg
4.52
5Y Avg
5.45
Market Cap
$6.48B
Current Ratio
2.20
TTM Avg
1.79
3Y Avg
1.77
5Y Avg
1.94
Market Cap
$5.95B
Current Ratio
31.18
TTM Avg
15.58
3Y Avg
12.00
5Y Avg
10.69
Market Cap
$5.87B
Current Ratio
3.90
TTM Avg
3.54
3Y Avg
4.15
5Y Avg
5.24
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Rhythm Pharmaceuticals, Inc. (RYTM) | $6.23B | 3.45 | 3.91 | 4.52 | 5.45 |
| Amneal Pharmaceuticals, Inc. (AMRX)vs › | $6.48B | 2.20 | 1.79 | 1.77 | 1.94 |
| Ligand Pharmaceuticals Incorporated (LGND)vs › | $5.95B | 31.18 | 15.58 | 12.00 | 10.69 |
| Lantheus Holdings, Inc. (LNTH)vs › | $6.51B | 3.06 | 4.11 | 4.19 | 3.61 |
| GRAIL Inc. (GRAL)vs › | $5.89B | 10.95 | 11.32 | 6.44 | 5.89 |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.57B | 0.93 | 1.84 | 2.80 | 3.67 |
| Kiniksa Pharmaceuticals International, plc (KNSA)vs › | $5.87B | 3.90 | 3.54 | 4.15 | 5.24 |
| Immunovant, Inc. (IMVT)vs › | $6.63B | 7.27 | 10.13 | 10.82 | 12.77 |
| Chemed Corporation (CHE)vs › | $6.66B | 0.91 | 1.21 | 1.24 | 1.14 |
| Iovance Biotherapeutics, Inc. (IOVA)vs › | $5.79B | 4.35 | 3.47 | 3.74 | 5.38 |
Current Ratio
3.45
Quick Ratio
3.20
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 3.45 |
| 2026-03-31 | 4.17 |
| 2025-12-31 | 4.41 |
| 2025-09-30 | 4.75 |
| 2025-06-30 | 2.79 |
| 2025-03-31 | 3.30 |
| 2024-12-31 | 3.24 |
| 2024-09-30 | 3.49 |
| 2024-06-30 | 6.53 |
| 2024-03-31 | 4.35 |
| 2023-12-31 | 5.58 |
| 2023-09-30 | 6.57 |
| 2023-06-30 | 6.16 |
| 2023-03-31 | 6.91 |
| 2022-12-31 | 8.90 |
| 2022-09-30 | 10.93 |
| 2022-06-30 | 5.59 |
| 2022-03-31 | 5.36 |
| 2021-12-31 | 7.10 |
| 2021-09-30 | 14.30 |
| 2021-06-30 | 21.68 |
| 2021-03-31 | 24.46 |
| 2020-12-31 | 10.10 |
| 2020-09-30 | 13.25 |
| 2020-06-30 | 15.96 |
| 2020-03-31 | 15.14 |
| 2019-12-31 | 12.38 |
| 2019-09-30 | 6.78 |
| 2019-06-30 | 7.80 |
| 2019-03-31 | 18.32 |
| 2018-12-31 | 19.05 |
| 2018-09-30 | 35.44 |
| 2018-06-30 | 40.12 |
| 2018-03-31 | 24.81 |
| 2017-12-31 | 22.42 |
| 2017-09-30 | 5.87 |
| 2017-06-30 | 8.04 |
| 2017-03-31 | 5.96 |
| 2016-12-31 | 2.36 |
| 2016-09-30 | 0.00 |
| 2016-06-30 | 0.00 |
| 2016-03-31 | 0.00 |
| 2015-12-31 | 6.73 |
| 2015-09-30 | 12.48 |
| 2015-06-30 | 0.23 |
| 2015-03-31 | 0.23 |
| 2014-12-31 | 0.35 |
| 2014-09-30 | 0.00 |
| 2014-06-30 | 4.37 |
| 2014-03-31 | 0.00 |
| 2013-12-31 | 5.93 |
